Recent Quotes

"Sales of VIV's OxC-beta should begin to increase throughout 2022."

— David Bautz, Zacks Small-Cap Research (1/31/22)
more >

"We are very encouraged how VIV continues to expand its customer base and increase the size and frequency of orders for OxC-beta Livestock."

— David Bautz, Zacks Small-Cap Research (6/14/21)
more >



Due to permission requirements, not all quotes are shown.